Serum substance P level as a marker for subclinical rheumatoid arthritis activity

References

• Abbasifard M, Imani D, Bagheri-Hosseinabadi Z. PTPN22 gene polymorphism and susceptibility to rheumatoid arthritis (RA): updated systematic review and meta-analysis. J Gene Med. 2020 Sep;(9):e3204.
   PubMed Web of Science ®Google Scholar
• Safiri S, Kolahi AA, Hoy D, et al. Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017. Ann Rheum Dis. 2019 Nov;78(11):1463–1471.
   PubMed Web of Science ®Google Scholar
• Viatte S, Plant D, Raychaudhuri S. Genetics and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol. 2013 Mar;9(3):141–153.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018 Feb 8;4(1):18001.
   PubMedGoogle Scholar
• Gulati M, Farah Z, Mouyis M. Clinical features of rheumatoid arthritis. Medicine. 2018;46(4):211–215.
   Google Scholar
• Arora S, Rafiq A, Jolly M. Management of rheumatoid arthritis: review of current guidelines. J Arthroscopy Joint Surg. 2016;3(2):45–50.
   Google Scholar
• Mashaghi A, Marmalidou A, Tehrani M, et al. Neuropeptide substance P and the immune response. Cell Mol Life Sci. 2016 Nov;73(22):4249–4264.
   PubMed Web of Science ®Google Scholar
• Suvas S. Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis. J Immunol. 2017;199(5):1543–1552.
   PubMed Web of Science ®Google Scholar
• Lambrecht BN, Germonpre PR, Everaert EG, et al. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol. 1999;29:3815–3825.
   PubMed Web of Science ®Google Scholar
• Gautam M, Prasoon P, Kumar R, et al. Role of neurokinin type 1 receptor in nociception at the periphery and the spinal level in the rat. Spinal Cord. 2016 Mar;54(3):172–182.
   PubMed Web of Science ®Google Scholar
• Muñoz M, Coveñas R. Involvement of substance P and the NK-1 receptor in human pathology. Amino Acids. 2014 Jul;46(7):1727–1750.
   PubMed Web of Science ®Google Scholar
• Rodriguez PL, Jiang S, Fu Y, et al. The proinflammatory peptide substance P promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions. Int J Cancer. 2014 Mar 1;134(5):1034–1044.
   PubMed Web of Science ®Google Scholar
• Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008 Nov;118(11):3537–3545.
   PubMed Web of Science ®Google Scholar
• Origuchi T, Iwamoto N, Kawashiri SY, et al. Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor. Mod Rheumatol. 2011 Jun;21(3):244–250.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010 Sep;62(9):2569–2581.
   PubMed Web of Science ®Google Scholar
• Canhão H, Rodrigues AM, Gregório MJ, et al. Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations. Front Med. 2018 Mar 8;5:40. DOI:10.3389/fmed.2018.00040.
   PubMed Web of Science ®Google Scholar
• Greenmyer JR, Stacy JM, Sahmoun AE, et al. DAS28-CRP Cutoffs for High Disease Activity and Remission are Lower Than DAS28-ESR in Rheumatoid Arthritis. ACR Open Rheumatol. 2020 Sep;2(9):507–511.
   PubMedGoogle Scholar
• Lisowska B, Lisowski A, Siewruk K. Substance P and Chronic Pain in Patients with Chronic Inflammation of Connective Tissue. PLoS ONE. 2015 Oct 7;10(10):e0139206.
   PubMed Web of Science ®Google Scholar
• Kamel SR, Sadek HA, Mohamed FA, et al. Role of ultrasound disease activity score in assessing inflammatory disease activity in rheumatoid arthritis patients. Egypt Rheumatol. 2018;40(1):1–5.‏
   Google Scholar
• Hurnakova J, Hulejova H, Zavada J, et al. Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission. PLoS ONE. 2016 Nov 10;11(11):e0165498.
   PubMed Web of Science ®Google Scholar
• Krenn V, Morawietz L, Häupl T, et al. Grading of chronic synovitis–a histopathological grading system for molecular and diagnostic pathology. Pathol Res Pract. 2002;198(5):317–325.
   PubMed Web of Science ®Google Scholar
• Lagrutta M, Alle G, Parodi RL, et al. Severe extra-articular manifestations of rheumatoid arthritis in absence of concomitant joint involvement following long-term spontaneous remission. A case report. Reumatol Clin. 2016 Jul-Aug;12(4):223–225.
   PubMedGoogle Scholar
• Markusse IM, Dirven L, Gerards AH, et al. Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study. Arthritis Res Ther. 2015 Aug 31;17(1):232.
   PubMedGoogle Scholar
• Hammer HB, Fagerhol MK, Wien TN, et al. The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab. Arthritis Res Ther. 2011;13(5):R178.
   PubMed Web of Science ®Google Scholar
• Nagy G, van Vollenhoven RF. Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now? Arthritis Res Ther. 2015 Aug 3;17(1):181.
   PubMedGoogle Scholar
• El-Serougy EM, Eesa NN, El-Azizi HM, et al. Power Doppler ultrasound in the evaluation of hand joints in rheumatoid arthritis patients in clinical remission: association with composite index scores and functional status. Egypt Rheumatol. 2019;41(1):7–10.
   Web of Science ®Google Scholar
• Wu H, Liao W, Li Q, et al. Pathogenic role of tissue-resident memory T cells in autoimmune diseases. Autoimmun Rev. 2018 Sep;17(9):906–911.
   PubMed Web of Science ®Google Scholar
• Santos-Moreno P, Castro CA, Villarreal L, et al. Prevalence of Sexual Disorders in Patients with Rheumatoid Arthritis and Associated Factors. Sex Med. 2020 Sep;8(3):510–516.
   PubMed Web of Science ®Google Scholar
• Oweis AO, Alawneh KM, Alshelleh SA, et al. Renal dysfunction among rheumatoid arthritis patients: a retrospective cohort study. Ann Med Surg (Lond). 2020 Nov 4;60:280–284. DOI:10.1016/j.amsu.2020.11.011.
   PubMed Web of Science ®Google Scholar
• Taneja V. Sex Hormones Determine Immune Response. Front Immunol. 2018 Aug 27;9:1931. DOI:10.3389/fimmu.2018.01931.
   PubMedGoogle Scholar
• Anichini M, Cesaretti S, Lepori M, et al. Substance P in the serum of patients with rheumatoid arthritis. Rev Rhum Engl Ed. 1997 Jan;64(1):18–21.
   PubMedGoogle Scholar
• Marshall KW, Chiu B, Inman RD. Substance P and arthritis: analysis of plasma and synovial fluid levels. Arthritis Rheum. 1990 Jan;33(1):87–90.
   PubMedGoogle Scholar
• Grimsholm O, Rantapää-Dahlqvist S, Forsgren S. Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. Arthritis Res Ther. 2005;7(3):R416–26.
   PubMed Web of Science ®Google Scholar
• Barbosa-Cobos RE, Lugo-Zamudio G, Flores-Estrada J, et al. Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis. Clin Rheumatol. 2018 Apr;37(4):901–908.
   PubMed Web of Science ®Google Scholar
• Delgado DA, Lambert BS, Boutris N, et al. Validation of Digital Visual Analog Scale Pain Scoring with a Traditional Paper-based Visual Analog Scale in Adults. J Am Acad Orthop Surg Glob Res Rev. 2018 Mar 23;2(3):e088.
   PubMedGoogle Scholar
• Younis AA, Jassim NA, Aliasghar A. Assessment of Disease Activity in Rheumatoid Arthritis: a Comparative Study of Clinical Evaluation with Ultrasonogra-phy. Iraqi Postgraduate Med J. 2016;15(2):202–210.
   Google Scholar
• Szkudlarek M, Wakefield RJ, Backhaus M, et al. The discriminatory capacity of ultrasound in rheumatoid arthritis: active vs inactive, early vs advanced, and more. Rheumatology (Oxford). 2012 Dec;51(Suppl 7):vii6–9.
   PubMedGoogle Scholar
• Slansky E, Li J, Häupl T, et al. Quantitative determination of the diagnostic accuracy of the synovitis score and its components. Histopathology. 2010 Sep;57(3):436–443.
   PubMed Web of Science ®Google Scholar
• Adel N, William M, Al Swaff R, et al. Serum calprotectin level for diagnosis and detection of disease activity in rheumatoid arthritis. Int J Immunol. 2014;2(1):6–10.
   Google Scholar